company

ORIFARM NORWAY AS

0484 OSLO

Return on Equity
834,54 %
Current Ratio
1,29
Debt-to-Equity Ratio
1,67
Key figures (EUR)2022
Revenue136 672 000
Net Income106 813 000
Total Assets151 540 000
Total Equity12 799 000
Income (EUR)2022
Revenue136 672 000
Expenditure127 000
Operating Profit136 545 000
Financial Income625 000
Financial Costs28 000
Financial Balance597 000
Earnings Before Tax137 142 000
Tax30 329 000
Net Income106 813 000
Balance (EUR)2022
Total Fixed Assets0
Total Current Assets151 540 000
Total Assets151 540 000
Total Retained Equity12 796 000
Total Equity12 799 000
Total Long-Term Debt21 369 000
Total Current Debt117 371 000
Total Equity and Debt151 540 000
Cash flow (EUR)2022
Sales Income0
Other Income136 672 000
Revenue136 672 000
Cost of Goods Sold0
Salary Costs92 000
Depreciation0
Impairment0
Expenditure127 000
Operating Profit136 545 000
Financial Income625 000
Financial Costs28 000
Financial Balance597 000
Dividends108 000 000
Net Income106 813 000
Balance details (EUR)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank113 000
Total Current Assets151 540 000
Total Assets151 540 000
Total Equity12 799 000
Short-Term Group Debt0
Total Long-Term Debt21 369 000
Creditors23 000
Unpaid Taxes110 000
Dividends108 000 000
Other Current Debt279 000
Total Current Debt117 371 000
Total Equity and Debt151 540 000
Financial indicators2022
Return on Equity834,54 %
Debt-to-Equity Ratio1,67
Operating Profit Margin99,91 %
Current Ratio1,29
Quick Ratio1,29
Equity Ratio0,08
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English